May. 19 at 9:07 PM
$CTOR Citius Oncology files Preliminary Notice of Stockholder Action By Written Consent to approve exercise of warrants issued May 5
https://www.sec.gov/Archives/edgar/data/1851484/000121390026059053/ea0290807-pre14c_citius.htm
On May 5, Citius Oncology entered into a loan agreement and warrant transaction. Per their SEC filing filed on May 6, CTOR is required to seek shareholder approval of the warrants issued.
Today, they filed a Preliminary Notice of Stockholder Action by Written Consent. The shareholder approval of the warrants will pass because the majority shareholder (parent company
$CTXR ) will vote in favor. Therefore, no action or vote will be required of CTOR shareholders.
Dates in the preliminary filing are still redacted. They will be finalized when CTOR files the definitive notice with the SEC.
